交易中 09-19 12:22:22 美东时间
0.000
0.00%
The latest update is out from Galectin Therapeutics ( ($GALT) ). Galectin Thera...
09-09 20:28
Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, ...
08-13 20:00
Galectin Therapeutics Inc- Qtrly Shr Loss $0.20
08-13 19:59
Galectin Therapeutics: Believes It Has Sufficient Cash to Fund Planned Operatio...
08-13 19:58
Galectin Therapeutics: Navigate Trial on Track for Interim Top-Line Analysis in...
08-13 19:57
Galectin Therapeutics Appoints Khurram Jamil, M.d. to Chief Medical Officer
08-01 20:00
Galectin Therapeutics press release (NASDAQ:GALT): Q1 GAAP EPS of -$0.19. As of March 31, 2024, the company had $23.6 million of cash and cash equivalents. The company believes it has sufficient cash ...
05-15 20:50
Analysts have been eager to weigh in on the Healthcare sector with new ratings ...
04-10 00:10
Madrigal Pharmaceuticals (NASDAQ:MDGL) said that its recently approved NASH/MASH drug Rezdiffra is now available in the US through a specialty pharmacy network. Rezdiffra, also known as resmetirom, re...
04-09 22:03
Gainers: Longeveron (LGVN) +66%. Titan Pharmaceuticals (TTNP) +23%. MSP Recovery (LIFW) +19%. Outset Medical (OM) +16%. Palatin Technologies (PTN) +11%. Losers: Zhongchao (ZCMD) -11%. Adial Pharmaceut...
04-08 22:00